Skip to main content

Table 2 Cancer-specific mortality

From: The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females

Characteristics Univariable Multivariable
HR 95% CI p value HR 95%CI p value
Age (years) 1.021 0.983–1.111 0.401  
BMI (kg/m2) 0.932 0.821–1.120 0.212
SBP (mmHg) 1.122 0.913–1.342 0.514
DBP (mmHg) 0.932 0.821–1.104 0. 314
Triglycerides (mmol/L) 0.915 0.832–1.214 0.423
HDL (mmol/L) 1.224 1.192–1.913 0.021* 1.201 0.925–1.651 0.312
LDL (mmol/L) 1.231 1.017–1.453 0.015* 1.218 0.941–2.092 0.513
Fasting glucose (mmol/L) 1.011 0.932–1.329 0.614  
CEA (ng/ml) 1.102 0.962–1.322 0.070
Differentiation 0.912 0.813–0.968 0.010* 0.858 0.771–0.972 0.025*
Location 1.225 0.832–1.564 0.243  
 Ascending, transverse, and descending 1.000
 Sigmoid 1.132 0.923–1.231 0.632
 Rectum 1.342 0.831–1.532 0.452
Stage 1.332 1.024–2.012 0.002* 1.523 1.132–2.432 0.009*
 I 1.000 1.000
 II 1.028 0.821–1.223 0.298 1.131 0.882–1.251 0.328
 III 2.852 1.852–3.832 0.001* 2.432 1.632–3.212 0.001*
MetS 1.621 1.221–2.133 0.007* 1.558 1.153–2.012 0.012*
NAFLD 1.544 1.031–1.893 0.010* 1.494 1.126–1.961 0.015*
 Non 1.000 1.000
 Mild 1.101 0.821–1.231 0.401 1.121 0.901–1.314 0.212
 Moderate 1.452 1.113–2.371 0.001* 1.501 1.161–2.481 0.010*
 Severe 1.612 1.224–2.471 0.010* 1.631 1.231–2.531 0.005*
  1. NAFLD, non-alcoholic fatty livers disease, MetS metabolic syndrome, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. *represent the p value ≤ 0.05